首页>
外国专利>
INTRATHECAL ADMINISTRATION OF TRIPTAN COMPOSITIONS TO TREAT NON-MIGRAINE PAIN
INTRATHECAL ADMINISTRATION OF TRIPTAN COMPOSITIONS TO TREAT NON-MIGRAINE PAIN
展开▼
机译:鞘内注射曲普坦组合物治疗非偏头痛
展开▼
页面导航
摘要
著录项
相似文献
摘要
Intrathecal delivery of a pharmaceutically acceptable formulation for intrathecal administration of any drug selectively binding to this receptor to provide pain can be used in any situation in which intrathecal ("IT") drugs are presently used for pain management. In the preferred embodiment, the drug is a triptan. In another embodiment, a combination of drugs with triptans can be used instead of just the triptan. Exemplary conditions to be treated include cancer pain, chronic back pain, post-herpetic neuralgia, and complex regional pain syndrome types I or II, as well as post-traumatic pain, diabetic vasculopathy, inflammatory radiculopathy, inflammatory plexopathies such as brachial plexopathy (Parsonage Turner syndrome), or lumbar plexopathy, HIV neuropathy, chemotherapy-induced neuropathy (such as vincristine toxicity), erythromelalgia, and inherited painful disorders such as metachromatic leukodystrophy, Friedreich's ataxia, and Fabry's disease. The triptans can also be used in acute pain management, such as in labor management or spinal blockade for surgery, where a spinal formulation of sumatriptan could be combined with traditional opiates for synergistic or additive effects.
展开▼